ATAI DCF Valuation - ATAI Life Sciences NV

Watchlist Manager

Watchlist

Price: 3.7 USD 4.52% Market Closed

Market Cap: $1.3B

	ATAI Life Sciences NV NASDAQ:ATAI	DE
	PTC Therapeutics Inc NASDAQ:PTCT	US
C	CMC Corp VN:CMG	VN
	Jiangsu Hoperun Software Co Ltd SZSE:300339	CN
	Katek Se XETRA:KTEK	DE
H	Heartflow Inc NASDAQ:HTFL	US
T	Thu Duc Water Supply JSC VN:TDW	VN
	Astral Ltd NSE:ASTRAL	IN
	China National Culture Group Ltd HKEX:745	HK
A	Arex Industries Ltd BSE:526851	IN
	Hong Wei Asia Holdings Co Ltd HKEX:8191	HK
P	Pandora A/S F:3P7	DK
	Timbercreek Financial Corp TSX:TF	CA
	Defiance Silver Corp XTSX:DEF	CA
	Brookfield Corp NYSE:BN	CA
	Winland Holdings Corp OTC:WELX	US
	Synergie SE PAR:SDG	FR
	White Mountains Insurance Group Ltd NYSE:WTM	US
	Cogent Communications Holdings Inc NASDAQ:CCOI	US
A	Allied Gold Corp TSX:AAUC	CA
P	Pacific Bauxite NL ASX:PBX	AU

ATAI's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.